Diabetes therapies and drug development
Pharmacokinetics and Pharmacodynamics: What the Body Does to a Drug, and Back
Pharmacokinetics is what the body does to a drug, and pharmacodynamics is what the drug does to the body. The first traces a medicine's journey, how it is absorbed, spread through tissues, broken down, and cleared out; the second describes the effect it produces once it arrives, whether that is lowering blood sugar, easing pain, or something unwanted.
What do pharmacokinetics and pharmacodynamics mean?
Pharmacokinetics is what the body does to a drug, and pharmacodynamics is what the drug does to the body. The first traces a medicine's journey, how it is absorbed, spread through tissues, broken down, and cleared out; the second describes the effect it produces once it arrives, whether that is lowering blood sugar, easing pain, or something unwanted. Almost every rule about how a medicine is taken, and how safely, comes from reading these two stories side by side. This is general education, not medical advice, and your own medicines are a question for a clinician who knows your history.
Pharmacokinetics, shortened to PK, is the study of a drug's concentration over time. Pharmacodynamics, PD, is the study of how that concentration relates to the effect. PK sets the level; PD tells you what the level does.
What the body does to a drug: the ADME journey
Pharmacokinetics has a familiar shorthand, ADME, for the four things the body does to any drug: absorption, distribution, metabolism, and excretion. Together they decide how much active drug is in the blood, and for how long.
Absorption is how the drug reaches the bloodstream. A pill has to survive the stomach, dissolve, and cross the gut wall, and only a fraction of what you swallow may arrive intact. That surviving fraction is called bioavailability. An injection into a vein skips this step, one reason the same substance can behave differently by route.
Distribution is where the drug goes next. Some drugs stay mostly in the circulation; others spread widely into fat, muscle, or other tissues, and a few reach places the body guards carefully, such as the brain. How widely a drug spreads affects how much you need to reach a useful level.
Metabolism is how the body chemically changes the drug, mostly in the liver, usually into forms that are easier to remove. A few drugs arrive inactive and are switched on this way, but the common pattern is breakdown.
Excretion is how what remains leaves, chiefly through the kidneys into urine and the liver into bile. Metabolism and excretion together are called clearance, the body's rate of removing the drug, and clearance is quietly one of the most important numbers in pharmacology.
Two figures summarize the result. The peak is how high the concentration climbs after a dose, and how fast. The half-life is how long it takes that concentration to fall by half: a short one means frequent redosing to stay present, while a long one lingers and clears slowly, which is why some medicines are taken once a day and others several times.
What the drug does to the body: from concentration to effect
Pharmacodynamics picks up where kinetics leaves off. Once the drug is present, what does it actually do?
Most drugs work by binding to a specific target, often a receptor, an enzyme, or a channel, and nudging its activity up or down. The strength of the effect usually depends on how much drug reaches that target. Push the concentration higher and the effect grows, but not forever. Almost every drug reaches a ceiling where the targets are largely occupied and adding more brings little benefit while the risk of side effects keeps climbing. That rising-then-plateauing relationship is the dose response curve, and it sits at the heart of pharmacodynamics.
This is also where selectivity lives. A well-behaved drug acts strongly on its intended target and only weakly on others, and many side effects are the same molecule acting on a second target you did not want touched.
Why the two must be read together
Kinetics tells you the concentration over time; dynamics tells you the effect at a given concentration. Combine them and you can predict the effect over time, which is what matters to a person taking a medicine. Sometimes the two line up, and the effect rises and falls with the blood level. Often they do not: a drug can be nearly cleared while its effect persists, because it left a lasting change at its target. That gap is why a medicine cannot be judged by its blood level alone.
I saw this discipline up close during my years in global drug development at Novo Nordisk, where I contributed to clinical programs for GLP-1, insulin, and combination therapies. Much of that work is the patient study of these two curves and how they fit together, and my FDA clinical investigator training reinforced how much of the structure exists to protect the people in the studies and those who use a medicine later.
Why people differ, and why it shapes safety
A fixed dose meets a moving target, because people handle drugs differently. Kidney and liver function set clearance, so reduced organ function can let a drug build up higher than intended. Body size and composition change how widely it spreads. Genetics shapes the enzymes that perform metabolism, so two people taking the identical amount can end up with quite different blood levels. Age, other medicines, some foods, and pregnancy shift the handling too.
My doctoral research has centered on the genetics of how the body handles glucose and insulin, and the lesson that carried over is humility about variation. This is why so many dosing instructions feel fussy, spaced a certain way, taken with food, adjusted for kidney function. Each rule tries to keep a person's concentration inside the range where the pharmacodynamics are favorable, high enough to help and low enough to stay reasonably safe. That range is the therapeutic window, and both PK and PD define its edges.
What a careful reader can take from this
If you remember one thing, make it the pairing. Pharmacokinetics is the body acting on the drug, moving it in, around, apart, and out; pharmacodynamics is the drug acting on the body, producing effects that grow with concentration up to a ceiling. These curves are noisy and shift with illness and other drugs, so how a specific medicine fits you is a conversation with a qualified clinician who can weigh your conditions and your response against the evidence. These curves will not hand you a dose, but they explain why the dose is what it is.
References and sources
How this was researched. This explainer is built from the primary sources listed above and reflects Dr. Tojjar's own critical appraisal of that evidence. It explains and evaluates research and does not provide medical care.
This article is for general education and is not medical or professional advice. For guidance about your own health, talk with a qualified clinician.
Cite this article
Tojjar, D. (2024). Pharmacokinetics and Pharmacodynamics: What the Body Does to a Drug, and Back. Dr. Damon Tojjar. https://readingtheevidence.org/articles/what-pharmacokinetics-and-pharmacodynamics-mean/
This article is part of Dr. Tojjar's guide to Diabetes therapies and drug development.